Science

Creating Biosimilars Is So Much More Than Copy and Paste

Highly Similar

Biosimilars have the potential to expand patient access to more treatment options, but creating them is anything but copy and paste.

Medicines produced from the cells of living organisms are called biologics. They’re typically more difficult to manufacture than small-molecule drugs, and generics, or exact copies, can’t be produced.

This won't last long. One year of fearless reporting for only $35 $25.

Don't miss this subscriber exclusive article.